Joo Hwan Nho

Joo Hwan Nho

Auto-generated profile, based on publicly available information

Joo Hwan Nho

Department of Life Sciences, Korea University, Seoul, South Korea

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Science Immunology
Verified
Journal Article
Closed access
BHByron W. Hayes
Byron W. Hayes
Hae Woong ChoiHae Woong Choi
Hae Woong Choi
ARAbhay P.S. Rathore
Abhay P.S. Rathore
CBChunjing Bao
Chunjing Bao
JSJianling Shi
Jianling Shi
Soman AbrahamSoman Abraham
Soman Abraham
Urinary tract infections (UTIs) account for almost 25% of infections in women. Many are recurrent (rUTI), with patients frequently experiencing chronic pelvic pain and urinary frequency despite clearance of bacteriuria after antibiotics. To elucidate the basis for these bacteria-independent bladder symptoms, we examined the bladders of patients with rUTI. We noticed a notable increase in neuropeptide content in the lamina propria and indications of enhanced nociceptive activity. In mice subjected to rUTI, we observed sensory nerve sprouting that was associated with nerve growth factor (NGF) produced by recruited monocytes and tissue-resident mast cells. Treatment of rUTI mice with an NGF-neutralizing antibody prevented sprouting and alleviated pelvic sensitivity, whereas instillation of native NGF into naïve mice bladders mimicked nerve sprouting and pain behavior. Nerve activation, pain, and urinary frequency were each linked to the presence of proximal mast cells, because mast cell deficiency or treatment with antagonists against receptors of several direct or indirect mast cell products was each effective therapeutically. Thus, our findings suggest that NGF-driven sensory sprouting in the bladder coupled with chronic mast cell activation represents an underlying mechanism driving bacteria-independent pain and voiding defects experienced by patients with rUTI.

3 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
Hae Woong ChoiHae Woong Choi
Hae Woong Choi
JNJoo Hwan Noh
Joo Hwan Noh
JIJason Iskarpatyoti
Jason Iskarpatyoti
XZXiaoyi Zhu
Xiaoyi Zhu
CBChunjing Bao
Chunjing Bao
JKJörn Karhausen
Jörn Karhausen
The critical events that trigger sepsis progression into life-threatening septic shock remain unclear. In agreement with reports that link a drop in platelet count to a complicated clinical course in sepsis patients, here we report that, during sepsis, mouse platelets become activated, deposit systemically on vascular walls, and stimulate perivascular mast cells (MC) by releasing platelet activating factor (PAF). In mouse models and patient samples, MC activation correlates with the development of shock in sepsis and is mechanistically linked to shock by inducing systemic hypotension, vascular leakage and microvascular perfusion abnormalities. Preventing platelet or MC activation, or inhibiting the activity of the major MC granule constituent chymase, averts progression from sepsis to shock and reduces mortality of septic mice. Thus, our work establishes that, during sepsis progression, platelet microvascular adhesion leads to MC-mediated vascular changes to culminate in septic shock and septic shock-associated mortality.